Biocartis Group NV Announces Operating Results for the First Quarter of 2017; Provides Operating Guidance for the Fiscal 2017
For the fiscal 2017, the company reiterated installed base to grow with 250-275 Idylla(TM) instruments and 2017 annual commercial cartridge volume to be at least three times 2016 volume.